Literature DB >> 11087904

Quantitative evaluation of the rRNA in Alzheimer's disease.

A M da Silva1, S L Payão, B Borsatto, P H Bertolucci, M A Smith.   

Abstract

The ribosomal RNA (rRNA) genes are located in nucleolus during active transcription and are transcribed by RNA polymerase I. This group of genes is involved in transcription and translation processes which can modulate gene expression. The association between rRNA levels and aging has been reported. In the present study, we investigated the ratio of mature rRNA 28S and 18S in peripheral blood of 15 Alzheimer's disease (AD) patients, 15 elderly healthy controls and 15 healthy young controls. Our results showed a statistically significant decrease of the mature rRNA 28S/18S ratio in AD patients when compared with the elderly and young control groups. Thus we can suggest that there is a possible change in the transcriptional or maturation process or a preferential degradation of the 28S subunit in AD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087904     DOI: 10.1016/s0047-6374(00)00180-9

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  10 in total

Review 1.  Epigenetic control of aging.

Authors:  Ursula Muñoz-Najar; John M Sedivy
Journal:  Antioxid Redox Signal       Date:  2010-11-22       Impact factor: 8.401

2.  Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model.

Authors:  Paula Garcia-Esparcia; Georgios Sideris-Lampretsas; Karina Hernandez-Ortega; Oriol Grau-Rivera; Theodoros Sklaviadis; Ellen Gelpi; Isidro Ferrer
Journal:  Am J Neurodegener Dis       Date:  2017-06-15

3.  Common Aging Signature in the Peripheral Blood of Vascular Dementia and Alzheimer's Disease.

Authors:  Hongbo Luo; Guangchun Han; Jiajia Wang; Fan Zeng; Yuanming Li; Shaoju Shao; Fuhai Song; Zhouxian Bai; Xing Peng; Yan-Jiang Wang; Xiangqun Shi; Hongxing Lei
Journal:  Mol Neurobiol       Date:  2015-06-23       Impact factor: 5.590

4.  Insulin and insulin-like growth factor resistance in alcoholic neurodegeneration.

Authors:  Suzanne M de la Monte; Ming Tong; Ariel C Cohen; Donna Sheedy; Clive Harper; Jack R Wands
Journal:  Alcohol Clin Exp Res       Date:  2008-07-08       Impact factor: 3.455

5.  The genetics of Alzheimer's disease in Brazil: 10 years of analysis in a unique population.

Authors:  J R M Oliveira; A L Nishimura; R R Lemos; M Zatz
Journal:  J Mol Neurosci       Date:  2008-07-08       Impact factor: 3.444

6.  Amyloid-beta-peptide reduces the expression level of mitochondrial cytochrome oxidase subunits.

Authors:  Won Kyung Hong; Eun Hae Han; Dae Ghon Kim; Jung Yup Ahn; Jeong Soon Park; Bok Ghee Han
Journal:  Neurochem Res       Date:  2007-05-19       Impact factor: 3.996

Review 7.  Insights into lncRNAs in Alzheimer's disease mechanisms.

Authors:  Dingfeng Li; Juan Zhang; Xiaohui Li; Yuhua Chen; Feng Yu; Qiang Liu
Journal:  RNA Biol       Date:  2020-07-14       Impact factor: 4.652

8.  Impaired APP activity and altered Tau splicing in embryonic stem cell-derived astrocytes obtained from an APPsw transgenic minipig.

Authors:  Vanessa J Hall; Maiken M Lindblad; Jannik E Jakobsen; Anders Gunnarsson; Mette Schmidt; Mikkel A Rasmussen; Daniela Volke; Thole Zuchner; Poul Hyttel
Journal:  Dis Model Mech       Date:  2015-08-06       Impact factor: 5.758

Review 9.  Nuclear Tau and Its Potential Role in Alzheimer's Disease.

Authors:  Mahmoud Bukar Maina; Youssra K Al-Hilaly; Louise C Serpell
Journal:  Biomolecules       Date:  2016-01-07

10.  The Involvement of Aβ42 and Tau in Nucleolar and Protein Synthesis Machinery Dysfunction.

Authors:  Mahmoud B Maina; Laura J Bailey; Aidan J Doherty; Louise C Serpell
Journal:  Front Cell Neurosci       Date:  2018-08-03       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.